ADC Bio is a biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer. Read more

48 Followers on Owler
48 Followers on Owler
48 Followers on Owler
48 Followers on Owler

ADC Bio is a biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer. Read more

Alan Raymond's photo - Chairman of ADC Bio

Chairman

Alan Raymond

CEO Approval Rating

87/100

Founded:

2010

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

ADC Therapeutics is the top competitor of ADC Bio. ADC Therapeutics is headquartered in Epalinges, Vaud, and was founded in 2011. ADC Therapeutics competes in the Biotechnology field. ADC Therapeutics generates 58% the revenue of ADC Bio.

Araris is perceived as one of ADC Bio's biggest rivals. Araris was founded in Zurich, Zurich} in 2017. Like ADC Bio, Araris also operates in the Biotechnology industry. Compared to ADC Bio, Araris generates $3M less revenue.

OBT is seen as one of ADC Bio's top competitors. OBT is a Private company that was founded in Abingdon, England in 2003. Like ADC Bio, OBT also works within the Biotechnology industry. OBT has 22 fewer employees vs. ADC Bio.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $4M a good estimate for ADC Bio's revenue?

Acquisitions

No recent acquisitions found related to ADC Bio

ADC Bio Funding History

$564.8K$5.4M

Since ADC Bio was founded in 2010, it has participated in 6 rounds of funding. In total ADC Bio has raised $5.4M. ADC Bio's last funding round was on Dec 2020 for a total of $0

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Corporate Round
Dec 2020
--
Equity
Nov 2018
$3.2M
Equity
Apr 2018
$1.6M
Equity
Sep 2017
--
Equity
Dec 2011
$549.1K

Denbighshire County Council

Since ADC Bio was founded in 2010, it has participated in 6 rounds of funding. In total ADC Bio has raised $5.4M. ADC Bio's last funding round was on Dec 2020 for a total of $0

Investments

No recent investments found related to ADC Bio

ADC Bio News

May 14, 2019PharmiWeb

Unlocking Advanced ADC Manufacturing Innovation

14 May 2018, Wales: ADC Biotechnology (ADC Bio), together with Maven Capital Partners and Bioscience... See more »
February 19, 2019Pharmaceutical Manufacturing

At the Forefront of ADC Manufacturing

ADC BIO's innovative technology is helping to usher in oncology's new age of therapeutic agents... See more »
November 26, 2018BioPharm

ADC Bio Secures Additional Equity Round Investment

ADC Biotechnology (ADC Bio) announced on Nov. 14, 2018 that the company secured additional funding of... See more »
November 15, 2018Contract Pharma

ADC Bio Secures £2.5M Investment

Will ensure the achievement of specific business goals within the company's overarching corporate str... See more »
October 23, 2018BioPortfolio

ADC Biotechnology Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27092018 Prices from USD $250

SummaryADC Biotechnology Ltd ADC formerly Reaxa Biotech Ltd is a developer and commercializer of tech... See more »
June 11, 2018Manufacturing Chemist

ADCs need more efficient manufacturing processes

Welsh ADC Biotechnology, a company working to simplify and lower production costs for anti-cancer blo... See more »
June 8, 2018BioPortfolio

ADC Bio CDMOs can learn from biotechs to drive manufacturing innovation

CDMOs need to respond to biotech innovation at an R&D level to improve efficiency in antibodydrug con... See more »

ADC Bio Press Releases

ADC Bio Videos

Social Media

Headquarters

4 Friarsgate Whitefriars

Chester, EnglandCH1 1XG

44-1244-980850

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

ADC Bio is a biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer. ADC Bio was founded in 2010. ADC Bio's headquarters is located in Chester, England, GB CH1 1XG. It has raised 5.4M in 6 rounds. T...

CEO

ADC Bio's Chairman, Alan Raymond, currently has an approval rating of 87%. ADC Bio's primary competitors are ADC Therapeutics, Araris & OBT.

Website

adcbio.com

Frequently Asked Questions about ADC Bio

  1. When was ADC Bio founded?

    ADC Bio was founded in 2010
  2. Who is ADC Bio's CEO?

    ADC Bio's CEO is Alan Raymond
  3. How much revenue does ADC Bio generate?

    ADC Bio generates $4M in revenue
  4. How much funding does ADC Bio have?

    ADC Bio has historically raised $5.4M in funding
  1. Where is ADC Bio's headquarters?

    ADC Bio's headquarters is in Chester England, GB
  2. How many employees does ADC Bio have?

    ADC Bio has 38 employees
  3. What sector does ADC Bio operate in?

    ADC Bio is in Biotechnology
  4. Who are ADC Bio's competitors?

    ADC Bio's top competitors are ADC Therapeutics, Araris, OBT